David Seaburg
Chief Executive Officer chez STELLA DIAGNOSTICS INC.
Fortune : 7 775 $ au 31/03/2024
Profil
David Seaburg is currently the Chief Executive Officer & Director at Stella Diagnostics, Inc. and the Director at Stella Diagnostics LLC.
Previously, he worked as the Managing Director & Head-Sales Trading at Cowen & Co. LLC from 1998 to 2020.
He also served as the Director at RegenETP, Inc. from 2021 to 2023.
Mr. Seaburg obtained his undergraduate degree from Northeastern University in 1993.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
REGENETP INC.
0,97% | 20/03/2023 | 71 272 ( 0,97% ) | 7 127 $ | 31/03/2024 |
STELLA DIAGNOSTICS INC.
0,10% | 30/06/2022 | 9 000 ( 0,10% ) | 648 $ | 31/03/2024 |
Postes actifs de David Seaburg
| Sociétés | Poste | Début |
|---|---|---|
| STELLA DIAGNOSTICS INC. | Chief Executive Officer | 22/04/2022 |
Stella Diagnostics LLC
 Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Director/Board Member | 25/02/2021 |
Anciens postes connus de David Seaburg
| Sociétés | Poste | Fin |
|---|---|---|
| REGENETP, INC. | Chief Executive Officer | 01/09/2021 |
Cowen & Co. LLC
 Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Sales & Marketing | 01/05/2020 |
Formation de David Seaburg
| Northeastern University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| REGENETP, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cowen & Co. LLC
Cowen & Co. LLC Investment Banks/BrokersFinance Cowen & Co. LLC is a SEC-registered broker/dealer headquartered in New York City. The firm was founded in 2004 and is a subsidiary of Cowen Holdings, Inc., ultimately owned by The Toronto-Dominion Bank (TSE: TD) in Canada. Cowen & Co. offers industry-focused investment banking for growth-oriented companies, domain knowledge-driven research and a sales and trading platform for institutional investors. Their institutional sales and trading business serves both equity and fixed-income clients. Sales and trading execution platform is structured around the following key verticals: (1) healthcare (2) technology, telecommunications and media (TMT) (3) REITs and financials (4) aerospace and defense (5) consumer and (6) alternative energy. | Finance |
Stella Diagnostics LLC
Stella Diagnostics LLC Medical SpecialtiesHealth Technology Stella Diagnostics LLC engages in the provision of molecular diagnostic services. Its StellaDX’s mass spec proteomic assays offers physicians insight into the molecular properties of patients’ tissue to determine if the disease is stable, progressing or turning cancerous. The company is headquartered in New York, NY. | Health Technology |
| Stella Diagnostics, Inc. |
